Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs10914350 | chr1:31784671 | C/A | 0.00011 | 491 | 23.57 | 31.33 | 30.8 | KM Plot |
PRAD | rs10914367 | chr1:31846206 | A/G | 8.25E-6 | 494 | 22.87 | 31.3 | 30.87 | KM Plot |
PRAD | rs10920461 | chr1:202687707 | C/T | 0.000125 | 494 | 31.07 | 30.2 | 28.23 | KM Plot |
PRAD | rs10927882 | chr1:16327229 | T/C | 2.29E-5 | 494 | 31.38 | 27.13 | 67.52 | KM Plot |
PRAD | rs10929270 | chr2:239105774 | T/A | 5.94E-9 | 476 | 32.03 | 28.93 | 32.23 | KM Plot |
PRAD | rs10930817 | chr2:178782739 | A/G | 4.15E-5 | 493 | 30.78 | 31.93 | 20.48 | KM Plot |
PRAD | rs10932035 | chr2:204824652 | G/A | 2.95E-5 | 491 | 30.8 | 32.4 | 20.33 | KM Plot |
PRAD | rs10932036 | chr2:204825181 | A/T | 2.88E-5 | 494 | 30.8 | 31.63 | 20.33 | KM Plot |
PRAD | rs10932037 | chr2:204825346 | C/T | 2.89E-5 | 493 | 30.87 | 31.63 | 20.33 | KM Plot |
PRAD | rs10932038 | chr2:204825584 | C/T | 5.1E-5 | 494 | 17.65 | 31.4 | 30.93 | KM Plot |
PRAD | rs11017046 | chr10:131801825 | C/T | 2.53E-5 | 489 | 31.87 | 29.13 | 27.58 | KM Plot |
PRAD | rs11017047 | chr10:131801955 | C/A | 2.53E-5 | 489 | 31.87 | 29.13 | 27.58 | KM Plot |
PRAD | rs11017048 | chr10:131803392 | A/T | 5.13E-5 | 494 | 26.12 | 28.88 | 32.27 | KM Plot |
PRAD | rs11020593 | chr11:93649416 | A/C | 8.06E-5 | 485 | 31.4 | 30.93 | 26.37 | KM Plot |
PRAD | rs11036231 | chr11:1632108 | G/T | 0.000116 | 494 | 18.55 | 31 | 31.23 | KM Plot |